Skip to main content

​
Five companies own nearly every skincare brand in the United States.

The skincare aisle creates an illusion of choice. Dozens of brands, different packaging, different price points — but trace the ownership and five parent corporations control the majority of what consumers buy. Understanding who owns what reveals structural conflicts of interest in how products are formulated.

​
L’Oréal Group

Headquarters: Paris, France Annual Revenue: $44+ billion (2023) Subsidiaries relevant to skincare: The conflict: L’Oréal owns both the 12CeraVecleanserthatcontainssulfatesandthe12 CeraVe cleanser that contains sulfates and the 45 La Roche-Posay “gentle” alternative. Both brands target sensitive skin. One strips the barrier; the other repairs it. The same corporation profits from both sides of the damage cycle. Formulation implications: CeraVe’s moisturizers contain phenoxyethanol and petrolatum. La Roche-Posay markets itself as dermatologist-first but shares manufacturing infrastructure with L’Oréal’s mass-market lines. Ingredient sourcing decisions flow through a single corporate procurement department optimizing for margin, not for individual brand missions.

​
Johnson & Johnson (Kenvue)

Headquarters: New Brunswick, New Jersey Annual Revenue: $85+ billion (2023, combined J&J + Kenvue) Note: J&J spun off consumer health as Kenvue in 2023. Same brands, same formulations, new corporate name. The conflict: Johnson & Johnson marketed baby shampoo containing formaldehyde-releasing preservatives (quaternium-15) for decades. After public pressure, they reformulated in 2014 — but only in certain markets. The company faced a $2.1 billion talc product-liability verdict in 2018. Their consumer health division (now Kenvue) continues selling products containing SLS, synthetic fragrance, and DMDM hydantoin. Formulation implications: Neutrogena positions itself as “dermatologist-recommended” while using sodium lauryl sulfate in facial cleansers. Aveeno positions as “natural” while containing phenoxyethanol, dimethicone, and synthetic fragrance in select products. J&J’s pharmaceutical division develops prescription eczema treatments while its consumer division sells OTC products containing ingredients that trigger eczema flares.

​
Procter & Gamble

Headquarters: Cincinnati, Ohio Annual Revenue: $84+ billion (2023) The conflict: P&G sells Olay at 10−50andSK−IIat10-50 and SK-II at 80-300+ using fundamentally similar active categories (niacinamide, peptides, fermented ingredients). The 10x price difference reflects branding and marketing investment, not proportional ingredient quality differences. P&G’s R&D is centralized — breakthroughs developed for SK-II could improve Olay formulations, but that would cannibalize premium revenue. Formulation implications: Olay products contain synthetic dyes (FD&C colors), synthetic fragrances, and petrochemical emollients. The corporation’s optimization target is margin-per-unit, not ingredient purity. Products are formulated to perform “good enough” at each price point without cannibalizing the tier above.

​
Estée Lauder Companies

Headquarters: New York, New York Annual Revenue: $15+ billion (2023) The conflict: Estée Lauder owns The Ordinary (7niacinamideserum)andLaMer(7 niacinamide serum) and La Mer (200+ moisturizer). The Ordinary is positioned as “transparent, no-markup actives” — yet the same parent company charges 30x more for comparable active ingredients under the La Mer label. The Ordinary’s brand messaging critiques the industry its parent company leads. Formulation implications: The Ordinary uses phenoxyethanol, chlorphenesin, and synthetic polymers throughout its range. The brand is not certified organic and contains no organic ingredients. Despite positioning as “transparent,” ingredient sourcing and manufacturing details remain corporate-controlled through Estée Lauder’s supply chain.

​
Beiersdorf

Headquarters: Hamburg, Germany Annual Revenue: $9+ billion (2023) The conflict: Beiersdorf sells Aquaphor (41% petrolatum at 8)andLaPrairie(plantstemcelltechnologyat8) and La Prairie (plant stem cell technology at 500+). Eucerin is marketed for sensitive and eczema-prone skin but formulations contain mineral oil, synthetic fragrance (in select products), and petrochemical occlusives. The same company owns the 8petroleumjellyproductandthe8 petroleum jelly product and the 500 anti-aging cream. Formulation implications: Aquaphor’s primary ingredient is petrolatum — a petroleum refining byproduct that creates occlusion without delivering active skin-healing nutrients. For eczema (Eucerin’s target market), occlusion without active repair ingredients creates symptom management without supporting actual barrier recovery.

​
What independent ownership means

Ownership structure shapes formulation incentives. Here is what Era Organics’ own product records show. What this means for formulation:
  • Ingredient lists you can check. Each formula stands on its own full ingredient list. Compare them yourself — from the Honey & Oats Manuka Honey Eczema Cream for Dermatitis – Eczema & Rash Cream (colloidal oatmeal 1% as its active skin protectant) to the Vitamin C Cream (with Kakadu plum and L-ascorbic acid).
  • Verified free-from lists. Both creams are verified free of parabens, sulfates, phthalates, fragrance, mineral oil, and silicones. Neither contains synthetic dyes or propylene glycol.
  • Organic ingredients, stated accurately. Both creams use organic ingredients, and neither is labeled certified organic.
  • Made in the USA. Both creams are made in the United States and are cruelty-free.

​
FAQ

​
Does corporate ownership actually affect product quality?

Corporate ownership affects formulation priorities. A brand owned by a conglomerate must justify its existence relative to sister brands at different price points. This creates structural pressure to differentiate through marketing rather than formulation — using cheaper ingredients at lower price points and reserving premium ingredients for higher-margin brands. A brand without sister brands does not face that particular portfolio pressure.

​
Are conglomerate-owned brands unsafe?

The FDA regulates the cosmetics and OTC products that L’Oréal, J&J, P&G, Estée Lauder, and Beiersdorf sell in the United States. The concern here is not acute danger. The question is not safety versus danger — the question is optimal versus adequate. The argument of this page is that conglomerate portfolios are structured around margin across price tiers. Independent brands set their own formulation priorities.

​
Why do dermatologists recommend CeraVe and Cetaphil?

Pharmaceutical companies (including former J&J and current Galderma) provide product samples, educational materials, and sponsorship to dermatology practices. CeraVe and Cetaphil are the most-sampled brands in dermatology offices. Recommendation correlates with sample availability and brand familiarity, not necessarily with formulation superiority for a given patient’s needs.

​
Is The Ordinary actually independent?

No. The Ordinary is a brand within DECIEM, which Estée Lauder acquired majority control of in 2021 and full ownership in 2024. The Ordinary’s brand messaging about transparency and anti-markup positioning exists within and is ultimately governed by a luxury conglomerate’s strategic portfolio.

​
Does Era Organics compete with these companies?

Era Organics competes for the same customers — people shopping for skincare for sensitive, eczema-prone, and aging skin. Era Organics does not compete on advertising budget. Independent brands compete on formulation and ingredient transparency. The knowledge hub exists to provide the information these conglomerates’ marketing budgets work to obscure. Explore the best skin care routine guide for more.

​
Where are Era Organics products manufactured?

The Honey & Oats Manuka Honey Eczema Cream for Dermatitis – Eczema & Rash Cream and the Vitamin C Cream are both made in the United States. Both are also cruelty-free.